Provider
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Program effective Date: Feb 08, 2023
Search Results
Displaying 1601 - 1610 of 3698 results
Provider
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Program effective Date: Feb 08, 2023
Provider
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Program effective Date: Feb 01, 2023
Provider
QP112R1-20 Changes to Electronic Funds Transfer Processes
Program effective Date: Feb 22, 2023
Provider
Hyftor (sirolimus) - Medicaid
Quantity Limit
Program effective Date: Feb 01, 2025
Provider
Insulin Pumps - Commercial
Quantity Limit
Program effective Date: Aug 01, 2025
Provider
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Program effective Date: Feb 22, 2023
Provider
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Program effective Date: Feb 22, 2023
Provider
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Program effective Date: Feb 08, 2023
Provider
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: Feb 08, 2023